What Is a Delayed-Release Probiotic and How Does It Work?
A delayed-release probiotic capsule is designed to open past the stomach, closer to the intestine, so the bacteria spend less time in stomach acid. Here is how the capsule-in-capsule design works, what a human imaging study found, and what the evidence does not show.
A delayed-release probiotic is a capsule designed to open later in the digestive tract instead of in the stomach. The aim is to limit the time probiotic bacteria spend in stomach acid and to release them closer to the intestine. In one human imaging study, a capsule-in-capsule combination consistently opened after reaching the ileum.
Most probiotic labels tell you which bacteria are inside and how many. Very few tell you where the capsule is designed to open. Yet that is one of the things that decides how many of those bacteria are likely to reach the intestine alive.
This article explains what "delayed release" means, how a capsule-in-capsule design works, what the human imaging study found, and what it does not show.
Key takeaways
- A standard capsule releases its contents in the stomach. A delayed-release capsule is designed to release them later, closer to the intestine.
- A probiotic must be alive to count as a probiotic, and stomach acid, enzymes and bile salts can all reduce the number that survive.
- A capsule-in-capsule design puts one capsule inside another. The shells chosen decide when and where it opens.
- In a human MRI study of six healthy volunteers, a delayed-release capsule placed inside a second delayed-release capsule consistently opened after reaching the ileum, the last part of the small intestine.
- Release location is not proof of a health benefit. That has to be measured separately in people.
What does "delayed release" actually mean?
A standard capsule is designed to dissolve soon after it is swallowed, so its contents are released in the stomach. A delayed-release capsule is made from a shell that is designed to hold together for longer, so the contents are released further along the digestive tract. [3]
Packs describe this idea in several ways, including "delayed release", "slow release" and "double capsule". Whatever the wording, the useful questions are the same: where is this capsule designed to open, and has anyone checked?
For probiotics, the reason to delay release is simple. Probiotics are live microorganisms that provide a health benefit when taken in an adequate amount. [1, 2] Being alive is part of the definition. Anything that reduces the number of live organisms before they reach the intestine reduces the delivered dose.
Why would you want a probiotic to open later?
Because the stomach is designed to destroy microorganisms.
The stomach has a typical pH of about 1.5 to 3.5. Those conditions help protect you from unwanted bacteria in food, and they may damage probiotic bacteria in the same way. Organisms that survive the stomach then meet digestive enzymes and bile salts, which can damage bacterial cells and membranes. These stresses come one after another, and together they may greatly reduce the number of organisms that reach the later parts of the intestine alive. [3]
A delayed-release design tries to reduce how long the bacteria are exposed to those conditions. Releasing the contents after the stomach may reduce exposure to stomach acid, delay release until later in transit, and increase the chance that the bacteria are delivered to a later part of the intestine. [5]
How does a capsule-in-capsule design work?
One way to delay release is to put a smaller capsule inside a larger one. Each shell can be made from a material with different release characteristics, and the combination decides when and where the contents come out. [5]
That gives designers more than one option. Both shells can be made to resist the stomach, to push release as far along the digestive tract as possible. Or the outer shell can be made to open in the stomach while the inner shell holds together, so that two ingredients are released in two different places.
Different combinations behave differently, which is why the design has to be tested rather than assumed. A capsule described as "double" or "dual" is not automatically a delayed-release capsule. What matters is whether the specific combination has been shown to open where it is meant to.
What did the human imaging study find?
Researchers at the University of Greifswald ran a human imaging study to answer two plain questions: when do capsules open, and where in the digestive tract? [5]
The study was small and carefully designed:
| Feature | What the study did |
|---|---|
| Participants | Six healthy volunteers |
| Design | Open-label, single-centre, ten-way crossover |
| Method | MRI imaging plus a salivary tracer to detect when each capsule opened |
| What was tested | Several capsule-in-capsule combinations with different shell types |
| What was measured | The time and location of capsule opening |
| What was not measured | Whether the capsules improved any health outcome |
One combination stood out: a delayed-release capsule placed inside another delayed-release capsule of the same type. It showed the least variation of all the combinations tested and consistently opened only after reaching the ileum. The investigators concluded that this combination enabled reliable delivery to the distal small intestine, the last stretch before the colon. [5]
The detail that matters is which shell did the work. Reliable release that far along happened when the outer capsule was also a delayed-release shell. Combinations whose outer capsule was a standard one opened sooner, in the stomach or the upper part of the small intestine, and varied more between people. [5] So a double capsule is not one thing: what the outer shell is made of changes where the inner one ends up.
Two points keep this honest. First, six people is a small group, and all of them were healthy. Second, the study was about where capsules open. It did not test whether opening later improves symptoms or health, and the ileum result belongs to that one combination, not to capsule-in-capsule products generally.
Why does the ileum matter?
The ileum is the final part of the small intestine, just before the colon. It is the gateway to the large intestine, where most of the resident gut bacteria live. [5]
For a probiotic, the aim is usually not only to survive the stomach but to reach the later parts of the digestive tract, where it is more likely to interact with those resident bacteria. A capsule that opens in the ileum has already passed the stomach and most of the small intestine. [5]
The research describes this as a formulation question: release location can be designed, and delivery beyond the stomach and upper small intestine may be an advantage for ingredients meant to reach the later parts of the gut. [5] It does not say that later release is always better for every probiotic or every person.
Do delayed-release capsules protect the bacteria inside?
The imaging study answered "where". How many bacteria survive the journey is a separate question, covered in full in Do probiotics survive stomach acid?
In short, a laboratory model of human digestion called SHIME® was used to compare four formats. The delayed-release capsule tested kept about half of its bacteria through the simulated stomach and small intestine, while the liquid, powder and conventional capsule tested each kept less than 1%. [4] That result applies to the exact formulations tested, and a laboratory model measures survival, not health outcomes in people.
Delayed-release vs regular probiotics: what is the difference?
People often search for "delayed release probiotics vs regular". The table below sets out the difference as the research describes it. [3, 4, 5]
| Regular (conventional) capsule | Delayed-release capsule | |
|---|---|---|
| Where it is designed to open | In the stomach | Later in the digestive tract |
| Time in stomach acid | Longer | Designed to be shorter |
| What the design needs to show | That the strains and CFU are as stated | That, and where the capsule actually opens |
| Evidence to look for | Strain names, CFU at end of shelf life | The same, plus release-location or survival data |
Neither type is automatically the right choice. A regular capsule with well-studied strains still has evidence behind its strains. A delayed-release claim is strongest when there is release-location or survival data behind it.
Where Probitec DuoCap fits
Probitec DuoCap 30 and DuoCap 10 contain 15 billion CFU of one named strain, Lactobacillus acidophilus La-14, together with a prebiotic. The capsule is a capsule-in-capsule design made from plant fibre, and it uses the second approach described earlier: the outer capsule is designed to release the prebiotic in the stomach, and the inner capsule is designed to release the probiotic in the small intestine. That is a different combination from the one the imaging study singled out, which used a delayed-release shell on the outside as well, so the ileum finding above describes that combination and not this product. The design is intended to help protect probiotic bacteria until they reach the intestine, and the product may assist in supporting gut microbiome balance and digestive function.
The studies described in this article tested other capsule combinations and formulations. They were not tests of the finished Probitec product.
What should you look for on a delayed-release pack?
Three things. [3, 4, 5]
- A plain statement of where the capsule is designed to open. "Delayed release" on its own does not tell you where.
- What kind of study backs the design, and what it measured. A human imaging study shows where a capsule opens. A laboratory digestion study shows how many bacteria survive. Only a study in people can show a health benefit.
- The basics no capsule can make up for: strains named in full (genus, species and strain code) and a CFU count stated at the end of shelf life.
For the full set of questions to ask about any probiotic, see How to choose a probiotic.
Delayed-release probiotics: the bottom line
A delayed-release probiotic is designed to open later in the digestive tract so that fewer bacteria are exposed to stomach acid, enzymes and bile salts. In a small human imaging study, one capsule-in-capsule combination consistently opened after reaching the ileum, which shows that release location can be designed.
That is a useful finding, and a limited one. It shows where one capsule combination opens. It does not show that a delayed-release probiotic improves health, and a result for one combination does not carry over to another. When you compare products, look at where the capsule is designed to open and what kind of evidence stands behind it, alongside named strains and an end-of-shelf-life CFU count.
When to speak to a healthcare professional
A probiotic is not a replacement for medical advice or prescribed treatment. If you are pregnant, have a weakened immune system, are seriously ill or are managing a medical condition, speak to a doctor or pharmacist before starting one. Persistent or worsening digestive symptoms should be checked by a healthcare professional rather than managed with a supplement alone.
Practical takeaway
If you are choosing a probiotic this week, turn the pack over. Check that the strains are named in full and that the CFU count is stated at the end of shelf life. Then look for where the capsule is designed to open and what kind of study supports that. A study showing where a capsule opens tells you about the capsule, not about how you will feel.
Delayed-release probiotic frequently asked questions
What is a delayed-release probiotic?
A delayed-release probiotic is a capsule designed to release its contents later in the digestive tract rather than in the stomach. The aim is to reduce the time probiotic bacteria spend in stomach acid and to deliver them closer to the intestine. Evidence for this should come from release-location or survival studies.
What is the difference between delayed-release and regular probiotics?
A regular capsule releases its contents in the stomach. A delayed-release capsule is designed to open later, closer to the intestine, so the bacteria spend less time in stomach acid. How much difference that makes depends on the specific capsule and formulation, which is why testing matters.
Where does a delayed-release probiotic capsule open?
It depends on the design. In one human MRI study of six healthy volunteers, a delayed-release capsule placed inside a second delayed-release capsule consistently opened only after reaching the ileum, the last part of the small intestine. It was also the most consistent of all the combinations tested.
Is a double capsule the same as a delayed-release capsule?
Not necessarily. A double capsule, also called capsule-in-capsule, puts one capsule inside another. Whether it delays release depends on the shells used, and particularly on the outer one. In the imaging study, the combination that reliably opened after the ileum used a delayed-release shell for both capsules; combinations with a standard outer shell opened in the stomach or the upper small intestine.
Does a delayed-release capsule prove that a probiotic works?
No. Release location and survival are important because probiotics must be alive to count as probiotics. They are not the same as a health benefit. Whether a probiotic helps with anything has to be measured separately in studies in people.
Related delayed-release probiotic reading
- Do probiotics survive stomach acid?
- How to choose a probiotic
- Single-strain vs multi-strain probiotics
- Explore DuoCap delivery
Delayed-release probiotic references
- Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.
- FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. London (ON): FAO/WHO Working Group Report; 2002.
- Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV. Microencapsulation and oral delivery of probiotics. Int J Pharm. 2012;436(1-2):1-10.
- Govaert M, Rotsaert C, Vannieuwenhuyse C, Duysburgh C, Medlin S, Marzorati M, Jarrett H. Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition. Nutrients. 2024;16(16):2791.
- Rump A, Weiss FN, Schulz L, Meister R, Kohnhorst C, Hensel A. The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study. Pharmaceutics. 2021;13(12):2002.
Delayed-release probiotic evidence note
The survival and release-location findings discussed in this article are mechanistic evidence from a laboratory digestion model and a small human imaging study. They should not be read as direct proof of clinical benefit. This article is for general education and does not diagnose, treat, prevent or cure disease.